Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AUA 2023 Embargo Policy

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Apr 26, 2023 7:27pm

208 Views

Post# 35415894

RE:RE:AUA 2023 Embargo Policy

Thanks, it definitely appears many of us are of one thought, the latest of patient data for the AUA presentation. In my opinion the upcoming numbers will validate Theralase's potential SOC for NMIBC and of course a move into a very large revenue stream. Efforts by our soft & hard bashers in my opinion is pure greed to steal your shares, don't fall for it. Love the daily excitement. The hard efforts by this company should be loudly applauded, they will save so many lives, thank you to our hard working team and of course to Dr. Sherri McFarland.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario